Form 4: Avanos Medical Interim CEO Michael Greiner Reports Acquisition and Disposal of Common Stock

Sentiment:

SEC Form 4 Filing


Interim CEO Michael Greiner reports acquiring and disposing of Avanos Medical common stock, including time-based restricted share units (TRSUs).

Summary

  • Michael Greiner, Interim CEO of Avanos Medical, filed a Form 4 detailing changes in beneficial ownership.
  • On October 29, 2024, Greiner acquired 44,189 shares of common stock at $0 and disposed of 190,898 shares.
  • The acquisition represents time-based restricted share units (TRSUs) awarded under the company's 2021 Long Term Incentive Plan.
  • These TRSUs will vest on October 29, 2025, with immediate vesting upon termination without cause.
  • Each TRSU is equivalent to one share of common stock.

Sentiment

Score: 5

Explanation: This is a routine filing related to executive compensation and stock transactions. It doesn't inherently indicate positive or negative sentiment.

Industry Context

Form 4 filings are standard practice for company insiders to report transactions in their company's stock, ensuring transparency and compliance with SEC regulations.

Stakeholder Impact

  • Shareholders are informed about the transactions of company insiders, providing transparency into executive compensation and stock ownership.
  • Employees may be impacted by the vesting of TRSUs, which are part of the company's long-term incentive plan.

Key Dates

DateDescription
10/29/2024Date of transaction: Acquisition and disposal of common stock and TRSUs.
10/29/2025Vesting date for the time-based restricted share units (TRSUs), unless terminated without cause.
10/31/2024Date of signature for the Form 4 filing.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.